Biomarkers in Lung Diseases: from Pathogenesis to Prediction
to New Therapies
The
study of protein, lipid, genetic, and genomic biomarkers of lung disease is an
important tool for understanding the biology of human lung disease. Both
candidate biomarker approaches and high dimensional platforms can provide new
insights into pathogenesis and confirmation of the clinical relevance of
experimental findings. In recognition of the central role that biomarker
research plays in bridging basic and clinical research in human lung disease,
the American Journal of Physiology Lung Cellular and Molecular Physiology is
issuing a call for papers on the topic of “Biomarkers in Lung Disease:
from Pathogenesis to Prediction”. This call for papers requests high-quality
studies of human disease biomarkers in patient samples and tissues that enhance
our understanding of the pathogenesis of human lung diseases such as Pulmonary
Arterial Hypertension, Pulmonary Fibrosis, Acute Lung Injury, COPD, Acute Lung
Injury and Lung Cancer. A number of reviews by experts in the field will
also be solicited.
All
papers will be reviewed promptly, thoroughly, and fairly by members of the
Editorial Board and guest reviewers who are recognized experts in this field.
Accepted manuscripts will be published on line within two weeks after
acceptance under a distinct heading and will receive special attention and
handling. Only those papers not requiring extensive revision will be published
under this Highlighted Topic.
The
deadline for this Call for Papers is December 31, 2015
COPD is a genetic disorder. Smoking, dust and fume also the cause of this disease. The people have COPD should avoid smoking, dust and fume. COPD and diabetes treatment
ReplyDelete